Health Condition of Cannabis Consumers in the Canadian Population: A Population-based Observational Cohort Study
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Neurocognitive disorder
研究概览
简要总结
This study evaluates the health condition and its evolution with time of Cannabis consumers in the Canadian population.
详细描述
In Canada, legalization of recreational use is likely to have decreased the perception of risks associated with Cannabis use, and means that the reported adverse effects of Cannabis are not so important, suggesting that Cannabis may be useful for their illness as an alternative or complementary therapeutic.
More Canadian physicians prescribed Cannabis for their patients. Both Recreational and medical use of Cannabis increase and will continue to grow up in the next coming years. Regardless, the typology of Cannabis use, more information on the health condition of Cannabis consumers may be helpful for the medical prescription of Cannabis, in particular in older adults who are more at risk of side effects.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Living in Canada the last 20 years
- •Being 60 years and over
- •Being consumer of cannabis
排除标准
- •Living outside Canada the last 20 years
- •Have never consumed cannabis
结局指标
主要结局
Neurocognitive disorder
时间窗: around 20 years
The decrease of cognitive function changes the activities of daily living to older adults. Instrumental Activities of Daily Living Scale ( IADLs) will be used to assess independent living skills to people who are a diagnosis of mild cognitive impairment. A summary score range from 0 ( low function, dependent) to 8 ( high function, independent) will be given to each participant based on their daily activities.
次要结局
- Depression(around 20 years)
研究者
Olivier Beauchet
MD, Professor of Geriatrics
Jewish General Hospital